L. Miao — Shanxi Medical University

Area of research

Oncology · Pulmonary and Respiratory Medicine

Research interest

Research focused on Oncology and Tolerability, with related work in Post-hoc analysis, Pemetrexed, Post hoc. Notable publications include '77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or...', 'LBA58 Sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated non-squamous non-small cell lung cancer (EGFRm nsqNSCLC) who progressed on EGFR...', and '68P: Survival impact of immunotherapy(IO) after chemo-failure in EGFR-mutated NSCLCA post-hoc analysis of the Orient-31 trial'.

Recent publications

68P: Survival impact of immunotherapy(IO) after chemo-failure in EGFR-mutated NSCLCA post-hoc analysis of the Orient-31 trial

Journal of Thoracic Oncology 2025cited by 0position: middledoi

77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)

Immuno-Oncology Technology 2022cited by 5position: middledoi

LBA58 Sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated non-squamous non-small cell lung cancer (EGFRm nsqNSCLC) who progressed on EGFR tyrosine-kinase inhibitors (TKIs) therapy: Second interim analysis of phase III ORIENT-31 study

Annals of Oncology 2022cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2022–2025)F. Ye · The University of Texas MD Anderson Cancer Center2 papers (2022–2025)Chao Ding · Hebei Medical University2 papers (2022–2025)— · 2 papers (2022–2025)H. Jian · Guangzhou University of Chinese Medicine1 papers (2025–2025)Liang Han · Hangzhou Medical College1 papers (2025–2025)Q. Wang · Center for Life Sciences1 papers (2025–2025)— · 1 papers (2022–2022)Yin Cheng · Hong Kong Polytechnic University1 papers (2022–2022)An-Bu Liu · Xinjiang Medical University1 papers (2025–2025)— · 1 papers (2022–2022)Mingxia Sun · Shandong Provincial Hospital1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)S. Lu · Guangxi Medical University1 papers (2025–2025)— · 1 papers (2025–2025)— · 1 papers (2022–2022)— · 1 papers (2025–2025)Jinhai Wu · Guangzhou Medical University1 papers (2022–2022)Bai-Yu Liu · Harbin Medical University1 papers (2022–2022)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Pulmonary and Respiratory Medicine →